Paper19684573
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.
Ge D and 12 others. Nature, 2009. Cited by 2,917 papers, by iCite.
Cite this record
ConductScience Library. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Papers, record 19684573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19684573
- Disease
- chronic hepatitis C virus infection92 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Variation | Major topic |
| Hepacivirus | Major topic |
| Hepatitis C, Chronic | Major topic |
| Interferon-alpha | Major topic |
| Interleukins | Major topic |
| Polyethylene Glycols | Major topic |
| Viral Load | Major topic |
| Black or African American | |
| Chromosomes, Human, Pair 19 | |
| Clinical Trials as Topic | |
| Europe | |
| Asia, Eastern | |
| Gene Frequency | |
| Genome, Human | |
| Genome-Wide Association Study | |
| Genotype | |
| Hispanic or Latino | |
| Humans | |
| Interferon alpha-2 | |
| Interferons | |
| Pharmacogenetics | |
| Polymorphism, Single Nucleotide | |
| Recombinant Proteins | |
| Interferon Lambda |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01437969 | Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment. | Background | ClinicalTrials.gov | |
| NCT01707849 | The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation | Background | ClinicalTrials.gov | |
| NCT01949168 | A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV | Background | ClinicalTrials.gov | |
| NCT03090035 | Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment | Results | ClinicalTrials.gov |
Comments and corrections6
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 19759611 | Genomics: Hepatitis C virus gets personal. | https://conductscience.org/library/papers/19759611 | PubMed |
| Comment in | 20104509 | Snipping away at hepatitis C. | https://conductscience.org/library/papers/20104509 | PubMed |
| Comment in | 20133003 | Genetic polymorphism and response to treatment in chronic hepatitis C: the future of personalized medicine. | https://conductscience.org/library/papers/20133003 | PubMed |
| Comment in | 20136353 | Pharmacogenetics of hepatitis C therapy. | https://conductscience.org/library/papers/20136353 | PubMed |
| Comment in | 20175968 | Predicting response to pegylated interferon/ribavirin-based therapy in genotype 1 chronic hepatitis C patients: results of 3 independent genome-wide association studies. | https://conductscience.org/library/papers/20175968 | PubMed |
| Comment in | 20434505 | Genetic variation in interleukin-28B predicts hepatitis C treatment-induced viral clearance in genotype 1 patients: the dawn of a new era? | https://conductscience.org/library/papers/20434505 | PubMed |
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15731279 | Lambda interferon inhibits hepatitis B and C virus replication. | J Virol | 2005 | https://conductscience.org/library/papers/15731279 | PubMed |
| 2 | 18256235 | WGAViewer: software for genomic annotation of whole genome association studies. | Genome Res | 2008 | https://conductscience.org/library/papers/18256235 | PubMed |
| 3 | 19403902 | Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19403902 | PubMed |
| 4 | 19330875 | Diagnosis, management, and treatment of hepatitis C: an update. | Hepatology | 2009 | https://conductscience.org/library/papers/19330875 | PubMed |
| 5 | 18467494 | Interferon signaling and treatment outcome in chronic hepatitis C. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18467494 | PubMed |
| 6 | 8020885 | Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. | Hepatology | 1994 | https://conductscience.org/library/papers/8020885 | PubMed |
| 7 | 12469119 | IL-28, IL-29 and their class II cytokine receptor IL-28R. | Nat Immunol | 2003 | https://conductscience.org/library/papers/12469119 | PubMed |
| 8 | 12483210 | IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. | Nat Immunol | 2003 | https://conductscience.org/library/papers/12483210 | PubMed |
| 9 | 15057741 | Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. | Gastroenterology | 2004 | https://conductscience.org/library/papers/15057741 | PubMed |
| 10 | 15163776 | Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15163776 | PubMed |
| 11 | 11685208 | Population genetic structure of variable drug response. | Nat Genet | 2001 | https://conductscience.org/library/papers/11685208 | PubMed |
| 12 | 18834319 | Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. | Clin Infect Dis | 2008 | https://conductscience.org/library/papers/18834319 | PubMed |
| 13 | 19625712 | Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19625712 | PubMed |
| 14 | 17701901 | PLINK: a tool set for whole-genome association and population-based linkage analyses. | Am J Hum Genet | 2007 | https://conductscience.org/library/papers/17701901 | PubMed |
| 15 | 16135132 | Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. | J Evol Biol | 2005 | https://conductscience.org/library/papers/16135132 | PubMed |
| 16 | 18528940 | Treatment responses in Asians and Caucasians with chronic hepatitis C infection. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18528940 | PubMed |
| 17 | 16862161 | Principal components analysis corrects for stratification in genome-wide association studies. | Nat Genet | 2006 | https://conductscience.org/library/papers/16862161 | PubMed |
Cited by1,369
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,917 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927293 | HEPATITIS C: THE PATH TO ELIMINATION. | Trans Am Clin Climatol Assoc | 2026 | https://conductscience.org/library/papers/42927293 | PubMed |
| 42780231 | Role of IFNL4 Genotype in Hepatic Inflammation and Fibrosis due to Metabolic Dysfunction-Associated Steatotic Liver Disease. | Res Sq | 2026 | https://conductscience.org/library/papers/42780231 | PubMed |
| 42654738 | Immunological Determinants of Oncogenic Virus-Driven Cancers in Africa: Mechanisms, Co-Infections and Public Health Challenges. | Pathogens | 2026 | https://conductscience.org/library/papers/42654738 | PubMed |
| 42351723 | HCV-Induced Hepatocarcinogenesis: Molecular Mechanisms, Persistent Cancer Risk, and Future Perspectives. | Biomedicines | 2026 | https://conductscience.org/library/papers/42351723 | PubMed |
| 42327087 | Lineage-specific chromatin poising enforced by ETS-IRF composite elements determines the divergent interferon responses of plasmacytoid dendritic cells and epithelial cells. | bioRxiv | 2026 | https://conductscience.org/library/papers/42327087 | PubMed |
| 42296571 | Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42296571 | PubMed |
| 42282012 | Microbiota-dependent interferon-λ controls immunity of the uterus and maternal-fetal interface. | Res Sq | 2026 | https://conductscience.org/library/papers/42282012 | PubMed |
| 41882355 | The DNA virome varies with human genes and environments. | Nature | 2026 | https://conductscience.org/library/papers/41882355 | PubMed |
| 41659403 | Microbiota-dependent IFN-L controls uterine and placental immunity. | bioRxiv | 2026 | https://conductscience.org/library/papers/41659403 | PubMed |
| 41400734 | Pharmacological Treatment for Adamantinomatous Craniopharyngioma. | Curr Oncol Rep | 2025 | https://conductscience.org/library/papers/41400734 | PubMed |
| 41354652 | Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease. | Nat Commun | 2025 | https://conductscience.org/library/papers/41354652 | PubMed |
| 41332446 | Human immunity. | J Hum Immun | 2025 | https://conductscience.org/library/papers/41332446 | PubMed |
| 41076628 | Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine design. | Cell Rep | 2025 | https://conductscience.org/library/papers/41076628 | PubMed |
| 41018685 | Seasonal variation in respiratory syncytial virus-specific IgG concentrations in Northern Plains American Indian children with asthma. | J Allergy Clin Immunol Glob | 2025 | https://conductscience.org/library/papers/41018685 | PubMed |
| 41001506 | Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways. | medRxiv | 2025 | https://conductscience.org/library/papers/41001506 | PubMed |
| 40946137 | Paradoxical association between steatotic liver disease and favorable hepatic outcomes in HCV patients with SVRs. | Hepatol Int | 2025 | https://conductscience.org/library/papers/40946137 | PubMed |
| 40857072 | How Clinical Pharmacology Can Support Clinical Trial Diversity and Inclusion. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/40857072 | PubMed |
| 40739075 | Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40739075 | PubMed |
| 40606851 | Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trial. | Rheumatol Immunol Res | 2025 | https://conductscience.org/library/papers/40606851 | PubMed |
| 40595262 | Integrative bioinformatics frameworks for abdominal aortic aneurysm using GWAS meta-analysis, biological network construction, and structural modeling. | Sci Rep | 2025 | https://conductscience.org/library/papers/40595262 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AK9 | 221264 | PubTator's text mining | https://conductscience.org/library/genes/221264 | NCBI Gene |
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
| IFNL3 | 282617 | PubTator's text mining | https://conductscience.org/library/genes/282617 | NCBI Gene |
| IFNL4 | 101180976 | PubTator's text mining | https://conductscience.org/library/genes/101180976 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| RIBAVIRIN | CHEMBL1643 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1643 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19684573
GET https://conductscience.org/api/papers/v1/19684573/cited_by?page=2